
Conference Coverage
Latest News

Personalized mRNA Vaccine Marks a New Chapter in Melanoma Treatment

Meta-Analysis Finds Significantly Lower SCC Risk in Patients With Vitiligo

Personalized mRNA-Based Melanoma Vaccine Meets Primary Endpoints in Landmark Phase 3 Trial

GX-03 Cuts Itch-Related Cytokine IL-31 by Nearly 68% in AD Model

Parsing Perceptions: Survey Explores Clinician and Patient Clarity About the Value and Safety of Sunscreens
Videos

Shorts










Podcasts
Dermatology Times Digital Edition







Continuing Medical Education
All News

Joan Levy, PhD, chief science officer at the Melanoma Research Alliance, discussed the significance of Tudriqev's accelerated approval for patients with anti-PD-1-refractory melanoma.

Tattoo science goes skin deep, from ink placement and healing to adverse reactions, aftercare, and the dermatologic effects of pigment.

This review of the latest dermatological studies includes insights on brodalumab for plaque psoriasis, physiological characteristics of scalps with high sebum production, disease burden of anogenital PsO, and more.

Judson Brewer, MD, PhD, discussed how the trigger-behavior-result habit loop model can be applied to itch-scratch cycles in atopic dermatitis.

GBD 2021 shows urticaria burden in the Middle East and North Africa has stayed flat for 3 decades, but rates vary widely based on location, gender, age, and more.

LEO Pharma will acquire worldwide rights to dersimelagon, an investigational oral therapy under FDA review for EPP and XLP.

In the August letter from the editor in chief, Christopher Bunick, MD, PhD, explains bemotrizinol’s broad-spectrum UVA/UVB benefits and simple UV safety habits for sunscreen, pools, and wounds.

Social media skin care trends drive excess product use, skin barrier damage, delayed dermatologist visits, and worse acne—especially among TikTok and influencer-following users.

Our August issue tackles psoriasis, acne, aesthetics, sunscreen safety, and more.

The Emerging Role of Oral Peptide Therapeutics in Psoriasis and Beyond
Oral peptide pills are reshaping psoriasis care, from semaglutide breakthroughs to IL‑23 blocker icotrokinra—here's what dermatologists need to know now.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Are pimple patches really that effective in clearing acne or is it just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

Review 10 evidence-based answers on GPP pathophysiology, diagnosis, and IL-36-targeted management, drawn from National Psoriasis Foundation consensus and emergency medicine literature.

Persistent hives with throat tightness and abdominal pain suggest C1‑INH deficiency in chronic spontaneous urticaria—see when complement tests point to HAE.

According to new research, AI reads real-world smartphone photos to score 4 eczema severity signs, boosting EASI training accuracy and reducing rater variability.






















